146 related articles for article (PubMed ID: 8042928)
1. beta-Amyloid protein immunoreactivity in skin is not a reliable marker of Alzheimer's disease. An autopsy-controlled study.
Heinonen O; Soininen H; Syrjänen S; Neittaanmäki H; Paljärvi L; Kosunen O; Syrjänen K; Riekkinen P
Arch Neurol; 1994 Aug; 51(8):799-804. PubMed ID: 8042928
[TBL] [Abstract][Full Text] [Related]
2. Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease.
Armstrong RA
Neurosci Lett; 1994 Mar; 169(1-2):133-6. PubMed ID: 8047269
[TBL] [Abstract][Full Text] [Related]
3. Beta A4 protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the beta A4 amyloid precursor protein gene and sporadic Alzheimer's disease.
Cairns NJ; Chadwick A; Lantos PL; Levy R; Rossor MN
Neurosci Lett; 1993 Jan; 149(2):137-40. PubMed ID: 8474686
[TBL] [Abstract][Full Text] [Related]
4. Intraneuronal beta-amyloid immunoreactivity in the CNS.
Sparks DL
Neurobiol Aging; 1996; 17(2):291-9. PubMed ID: 8744411
[TBL] [Abstract][Full Text] [Related]
5. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
[TBL] [Abstract][Full Text] [Related]
6. Presence of non-fibrillar amyloid beta protein in skin biopsies of Alzheimer's disease (AD), Down's syndrome and non-AD normal persons.
Wen GY; Wisniewski HM; Blondal H; Benedikz E; Frey H; Pirttila T; Rudelli R; Kim KS
Acta Neuropathol; 1994; 88(3):201-6. PubMed ID: 7810290
[TBL] [Abstract][Full Text] [Related]
7. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
Hyman BT; Tanzi RE; Marzloff K; Barbour R; Schenk D
J Neuropathol Exp Neurol; 1992 Jan; 51(1):76-83. PubMed ID: 1740675
[TBL] [Abstract][Full Text] [Related]
8. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
9. Beta-Amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer's disease, Parkinson's disease, and Down syndrome.
Crino PB; Martin JA; Hill WD; Greenberg B; Lee VM; Trojanowski JQ
Ann Otol Rhinol Laryngol; 1995 Aug; 104(8):655-61. PubMed ID: 7639477
[TBL] [Abstract][Full Text] [Related]
10. Amyloid precursor protein accumulation in Lewy body dementia and Alzheimer's disease.
Van Gool D; De Strooper B; Van Leuven F; Dom R
Dementia; 1995; 6(2):63-8. PubMed ID: 7606281
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele.
Heinonen O; Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Sorvari H; Kosunen O; Paljärvi L; Ryynänen M; Riekkinen PJ
Neurobiol Aging; 1995; 16(4):505-13. PubMed ID: 8544899
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease.
Mann DM; Jones D; Prinja D; Purkiss MS
Acta Neuropathol; 1990; 80(3):318-27. PubMed ID: 1698007
[TBL] [Abstract][Full Text] [Related]
13. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease.
Heinonen O; Soininen H; Sorvari H; Kosunen O; Paljärvi L; Koivisto E; Riekkinen PJ
Neuroscience; 1995 Jan; 64(2):375-84. PubMed ID: 7700527
[TBL] [Abstract][Full Text] [Related]
14. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease.
Vinters HV; Nishimura GS; Secor DL; Pardridge WM
Am J Pathol; 1990 Aug; 137(2):233-40. PubMed ID: 2201197
[TBL] [Abstract][Full Text] [Related]
16. NF-kB immunoreactivity is observed in association with beta A4 diffuse plaques in patients with Alzheimer's disease.
Ferrer I; Martí E; López E; Tortosa A
Neuropathol Appl Neurobiol; 1998 Aug; 24(4):271-7. PubMed ID: 9775392
[TBL] [Abstract][Full Text] [Related]
17. A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.
Davies L; Wolska B; Hilbich C; Multhaup G; Martins R; Simms G; Beyreuther K; Masters CL
Neurology; 1988 Nov; 38(11):1688-93. PubMed ID: 3054625
[TBL] [Abstract][Full Text] [Related]
18. Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome.
Beyreuther K; Pollwein P; Multhaup G; Mönning U; König G; Dyrks T; Schubert W; Masters CL
Ann N Y Acad Sci; 1993 Sep; 695():91-102. PubMed ID: 8239320
[TBL] [Abstract][Full Text] [Related]
19. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
Coria F; Castaño EM; Frangione B
Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
[TBL] [Abstract][Full Text] [Related]
20. Detection of amyloid beta protein precursor immunoreactivity in normal and Alzheimer's disease cerebrospinal fluid.
Chong JK; Miller BE; Ghanbari HA
Life Sci; 1990; 47(13):1163-71. PubMed ID: 2122149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
